Wanbury is locked at upper circuit limit at Rs. 22.65, up by 3.75 points or 19.84% from its previous closing of Rs. 18.90 on the BSE.
The scrip opened at Rs. 20.50 and has touched a high and low of Rs. 22.65 and Rs. 19.65 respectively. So far 54,770 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 37.80 on 17-Jan-2013 and a 52 week low of Rs. 15.65 on 06-Aug-2013.
Last one week high and low of the scrip stood at Rs. 23.20 and Rs. 18.20 respectively. The current market cap of the company is Rs. 48.24 crore.
The promoters holding in the company stood at 41.36% while Institutions and Non-Institutions held 4.42% and 50.95% respectively.
Wanbury’s manufacturing facilities situated at Patalganga and Tanaku have been classified as acceptable by the Department of Health & Human Services, Public Health Service, Food and Drug Administration, USA (USFDA).
Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) and Contract Research and Manufacturing Services (CRAMS). It has a presence in Spain through its branded formulation business - Cantabria Pharma S. L acquired in 2006.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.95 |
Dr. Reddys Lab | 1339.60 |
Cipla | 1463.70 |
Lupin | 2129.30 |
Zydus Lifesciences | 965.25 |
View more.. |